{
    "title": "Novo Nordisk tells Europe weight-loss drug will save money as well as lives",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12444837/Novo-Nordisk-launch-Wegovy-countries-constrained-manner--CEO.html",
    "date": "2023-08-25",
    "keywords": [
        "wegovy",
        "jorgensen",
        "drug",
        "company",
        "europe",
        "month",
        "ceo",
        "demand",
        "health",
        "cost",
        "population",
        "market",
        "injection",
        "catalent",
        "strategy",
        "maggie",
        "fick",
        "jacob",
        "friday",
        "weightloss",
        "denmark",
        "norway",
        "trial",
        "access",
        "gronholtpedersen",
        "copenhagen",
        "treatment",
        "healthcare",
        "reimbursement",
        "bmi",
        "point",
        "view",
        "event",
        "firsttomarket",
        "class",
        "loss",
        "selfinjection",
        "wegovys",
        "attention",
        "drugmaker",
        "profit",
        "time",
        "territory",
        "situation",
        "youre",
        "world",
        "obesity",
        "end",
        "decade",
        "race",
        "share",
        "amgen",
        "pfizer",
        "biotech",
        "launch",
        "june",
        "production",
        "capacity",
        "experience",
        "need",
        "everyone",
        "medicine",
        "latestage",
        "benefit",
        "boost",
        "intervening",
        "data",
        "heart",
        "wider",
        "range",
        "novo",
        "contract",
        "manufacturer",
        "july",
        "factory",
        "sterilesafety",
        "staff",
        "quality",
        "facility",
        "filling",
        "germany",
        "reporting",
        "josephine",
        "mason",
        "mark",
        "potter"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}